Microbiome Company Seed™ Launches to Disrupt Probiotics, Set New Industry Standards
Seed™, a new microbiome company, launches today with the mission to set a new standard of scientific rigor and consumer education in the $38 billion global probiotics industry. Seed today also announces its first product, Daily Synbiotic™, a probiotic and prebiotic with both a female and male formulation. Seed’s team is led by Co-Founders and Co-CEOs, Ara Katz and Raja Dhir, and includes Chief Scientist, Dr. Gregor Reid, a pioneer in microbial sciences with 35 years of research, who chaired the United Nations – World Health Organization panel that first authored the global definition of the term ‘probiotics.’ Seed’s approach is a paradigm shift, bridging microbiome science and consumer health to bring much-needed precision, efficacy and education to consumer probiotics.
Seed™ launched in Los Angeles with funding from BOLD Capital, 8VC, Founders Fund, Collaborative Fund, Greycroft, The Chernin Group, Box Group, and Cross Culture Ventures.